Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 12/20 | 0.42 |
| ▸ | PPARG | P37231 | 7/20 | 0.42 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.41 |
| ▸ | CDK1 | P06493 | 1/20 | 0.40 |
| ▸ | ABL1 | P00519 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.39 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21667337 | 0.84 | CYP3A4 (0.53) | CYP3A4CYP2B6 | |
| SCHEMBL21667279 | 0.83 | CYP3A4 (0.54) | CYP3A4CYP2B6THRB | |
| SCHEMBL21667323 | 0.83 | CYP3A4 (0.54) | CYP3A4CYP2B6P2RX7 | |
| SCHEMBL21667350 | 0.82 | CYP3A4 (0.53) | CYP3A4CYP2B6CDK1 | |
| SCHEMBL21667335 | 0.80 | CYP3A4 (0.51) | CYP3A4CYP2B6P2RX7ABL1SRC | |
| SCHEMBL21667318 | 0.79 | CYP3A4 (0.50) | CYP3A4CYP2B6P2RX7 | |
| SCHEMBL20716038 | 0.79 | CYP3A4 (0.61) | CYP3A4CYP2B6CDK1 | |
| SCHEMBL16324979 | 0.78 | CYP3A4 (0.64) | CYP3A4CYP2B6 | |
| SCHEMBL16324981 | 0.78 | CYP3A4 (0.64) | CYP3A4CYP2B6 | |
| SCHEMBL21667339 | 0.76 | CYP3A4 (0.46) | CYP3A4CYP2B6P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3702352-A1 | PYRIMIDINEDIONE COMPOUND AGAINST CARDIAC CONDITIONS | Myokardia, Inc. (US) | 2020-09-02 | — | — | EP | disclosed |
| EP-3010910-B1 | PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS | MYOKARDIA INC (US) | 2020-02-05 | — | — | EP | disclosed |